genae, Experts in Value-driven Science & Technology for the Medical Industries, today announced the acquisition of MedicSense, a Clinical, Regulatory Affairs and Quality Assurance consultancy firm.
“The vast regulatory and quality assurance expertise of the MedicSense team represents a logical expansion of genae’s value chain of services”, said Bart Segers, CEO at genae. “Being involved in the early stages of the development process lowers the risk of potential re-engineering and accelerates the time to market, while remaining in compliance with worldwide regulatory requirements”.
“Integrating MedicSense in the genae group addresses the needs of the vibrant, high-tech medical device industry and the dynamic regulatory environment”, said Adi Ickowicz and Erez Adiv co-founders and CEO’s at MedicSense. “This approach favors the entire service industry and represents a major advantage for the larger multi-disciplinary and more comprehensive service providers”.
Date: January 14, 2019
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Genae